Close

Illumina (ILMN), MolecularMD to Collaborate on Companion Diagnostics for Biopharma Drug Programs

June 27, 2016 12:02 PM EDT Send to a Friend
MolecularMD Corporation announced today that it has entered into an agreement with Illumina, Inc. (NASDAQ: ILMN) that establishes a framework ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login